These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9263236)

  • 21. Audit of ranitidine administration in parenteral nutrient solutions.
    Hershey AG; Rosen GH; Foster MD; Johnson DS; Martir-Herrero ML; Krieger J; Oh SM
    Am J Hosp Pharm; 1991 Jan; 48(1):104-7. PubMed ID: 1900386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
    Burm JP; Jhee SS; Chin A; Moon YS; Jeong E; Nii L; Fox JL; Gill MA
    Am J Hosp Pharm; 1994 May; 51(9):1201-4. PubMed ID: 7913797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro stability of ranitidine hydrochloride in enteral nutrient formulas.
    Crowther RS; Bellanger R; Szauter KE
    Ann Pharmacother; 1995 Sep; 29(9):859-62. PubMed ID: 8547732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of propofol with parenteral nutrient solutions during simulated Y-site injection.
    Bhatt-Mehta V; Paglia RE; Rosen DA
    Am J Health Syst Pharm; 1995 Jan; 52(2):192-6. PubMed ID: 12879548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of caffeine injection in intravenous admixtures and parenteral nutrition solutions.
    Nahata MC; Zingarelli JR; Durrell DE
    DICP; 1989 Jun; 23(6):466-7. PubMed ID: 2500782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical characteristics of total parenteral nutrition bags significantly affect the stability of vitamins C and B1: a controlled prospective study.
    Dupertuis YM; Morch A; Fathi M; Sierro C; Genton L; Kyle UG; Pichard C
    JPEN J Parenter Enteral Nutr; 2002; 26(5):310-6. PubMed ID: 12216712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of famotidine in minibags refrigerated and/or frozen in total parenteral nutrition solutions.
    Bullock LS
    DICP; 1989 Oct; 23(10 Suppl):S44-6. PubMed ID: 2510411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of ranitidine admixtures frozen and refrigerated in minibags.
    Lampasona V; Mullins RE; Parks RB
    Am J Hosp Pharm; 1986 Apr; 43(4):921-5. PubMed ID: 3706338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stability of the mixture of a new fat emulsion with parenteral nutrition solutions].
    Tannuri U; Coelho MC; Sesso A; Maksoud JG
    AMB Rev Assoc Med Bras; 1989; 35(1):5-8. PubMed ID: 2513624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Intralipid, amino acids, container, temperature, and duration of storage on vitamin stability in total parenteral nutrition admixtures.
    Smith JL; Canham JE; Kirkland WD; Wells PA
    JPEN J Parenter Enteral Nutr; 1988; 12(5):478-83. PubMed ID: 3141645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Stability of Newborn Hospital Parenteral Nutrition Solutions.
    Otero-Millán L; Bea-Mascato B; Legido Soto JL; Martínez-López-De-Castro N; Lago-Rivero N
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of ranitidine in injectable solutions.
    Vehabovic M; Hadzovic S; Stambolic F; Hadzic A; Vranjes E; Haracic E
    Int J Pharm; 2003 Apr; 256(1-2):109-15. PubMed ID: 12695016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of potential and real cost savings by the addition of ranitidine to total parenteral nutrition solutions.
    Pearson VE; King LM
    Hosp Pharm; 1992 Jul; 27(7):610, 613-4. PubMed ID: 10119189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of ranitidine tablets subjected to stress and environmental conditions, by HPLC.
    Volonté MG; Yuln G; Mandrile A; Longo R; Cingolani A
    Boll Chim Farm; 2001; 140(5):316-21. PubMed ID: 11680085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of ascorbic acid stability in different multilayered parenteral nutrition bags: critical influence of the bag wall material.
    Dupertuis YM; Ramseyer S; Fathi M; Pichard C
    JPEN J Parenter Enteral Nutr; 2005; 29(2):125-30. PubMed ID: 15772391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of famotidine 20 and 40 mg/L and amino acids in total parenteral nutrient solutions.
    Bullock L; Fitzgerald JF; Glick MR; Parks RB; Schnabel JG; Hancock BG
    Am J Hosp Pharm; 1989 Nov; 46(11):2321-5. PubMed ID: 2511752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags.
    Kaushal G; Sayre BE; Prettyman T
    Drug Discov Ther; 2012 Feb; 6(1):49-54. PubMed ID: 22460429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of ranitidine in intravenous admixtures stored frozen, refrigerated, and at room temperature.
    Stewart JT; Warren FW; Johnson SM; Galante LJ
    Am J Hosp Pharm; 1990 Sep; 47(9):2043-6. PubMed ID: 2220860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability and delivery of vancomycin hydrochloride when admixed in a total parenteral nutrition solution.
    Schilling CG; Watson DM; McCoy HG; Uden DL
    JPEN J Parenter Enteral Nutr; 1989; 13(1):63-4. PubMed ID: 2494369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dilute iron dextran formulation for addition to parenteral nutrient solutions.
    Kwong KW; Tsallas G
    Am J Hosp Pharm; 1980 Feb; 37(2):206-10. PubMed ID: 6767401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.